News & Events

MELBOURNE, Australia, and MENLO PARK, California U.S.A. (13 September 2010) – ChemGenex Pharmaceuticals Limited (ASX: CXS) announced today that Greg Collier, PhD, Chief Executive Officer and Managing Director will present a company update at the Rodman and Renshaw 12th Annual Healthcare Conference in the Winslow Salon of the New York Palace Hotel on Tuesday, 14 September 2010 at 11:15 a.m. Eastern Time in the U.S. (Wednesday, 15 September 2010 at 1:15 a.m. in Eastern Australia).

Dr Collier will provide an update on the development of omacetaxine (OMAPRO^TM) and upcoming milestones. Dr Collier’s presentation, being the company’s corporate overview, can be accessed from the company’s website; http://www.chemgenex.com/investors/presentations/